- Home
- ACON vs IMCC Comparison
ACON vs IMCC Comparison
Compare ACON & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- IMCC
- Stock Information
- Founded
- ACON 2008
- IMCC 1980
- Country
- ACON United States
- IMCC Israel
- Employees
- ACON N/A
- IMCC N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ACON Technology
- IMCC Health Care
- Exchange
- ACON Nasdaq
- IMCC Nasdaq
- Market Cap
- ACON 4.5M
- IMCC 11.8M
- IPO Year
- ACON 2022
- IMCC N/A
- Fundamental
- Price
- ACON $7.30
- IMCC $2.31
- Analyst Decision
- ACON Buy
- IMCC
- Analyst Count
- ACON 2
- IMCC 0
- Target Price
- ACON $481.00
- IMCC N/A
- AVG Volume (30 Days)
- ACON 12.7K
- IMCC 45.1K
- Earning Date
- ACON 08-14-2025
- IMCC 08-12-2025
- Dividend Yield
- ACON N/A
- IMCC N/A
- EPS Growth
- ACON N/A
- IMCC N/A
- EPS
- ACON N/A
- IMCC N/A
- Revenue
- ACON $62,948.00
- IMCC $38,430,631.00
- Revenue This Year
- ACON $145.39
- IMCC $47.12
- Revenue Next Year
- ACON $145.45
- IMCC $12.83
- P/E Ratio
- ACON N/A
- IMCC N/A
- Revenue Growth
- ACON 16.68
- IMCC 5.08
- 52 Week Low
- ACON $6.20
- IMCC $1.29
- 52 Week High
- ACON $3,499.51
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ACON 50.24
- IMCC 40.65
- Support Level
- ACON $7.00
- IMCC $2.52
- Resistance Level
- ACON $7.75
- IMCC $3.13
- Average True Range (ATR)
- ACON 0.44
- IMCC 0.29
- MACD
- ACON 0.01
- IMCC -0.04
- Stochastic Oscillator
- ACON 47.06
- IMCC 15.46
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.